PAAPU
PLAINS ALL AMERICAN PIPELINE LP
No data for this timeframe.
Vol
SEC Reports5
Recent Activity
May 13, 2026
SEC
Plains All American Pipeline filed a DEFA14A supplementing its proxy statement to disclose the appointment of Cynthia B.
DEFA14A — Impact 2/10
May 13, 2026
SEC
Plains All American Pipeline appointed Cynthia B. Taylor as an independent board member, effective May 11, 2026. Ms. Tay
8-K — Impact 2/10
May 12, 2026
SEC
Plains All American Pipeline completed the sale of its Canadian NGL business to Keyera Corp. for approximately CAD $5.13
8-K — Impact 6/10
Analyst Ratings
5Strong Buy
7Buy
9Hold
3Sell
0Strong Sell
Latest Reports
NEUTRAL
DEFA14A
2/10
Plains All American Pipeline filed a DEFA14A supplementing its proxy statement to disclose the appointment of Cynthia B.
May 13, 2026
NEUTRAL
8-K
2/10
Plains All American Pipeline appointed Cynthia B. Taylor as an independent board member, effective May 11, 2026. Ms. Tay
May 13, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 1 mixed, 3 neutral. Avg impact: 4.0/10.
NEUTRAL
DEFA14A
2/10
Plains All American Pipeline filed a DEFA14A supplementing its proxy statement to disclose the appoi
May 13, 2026
NEUTRAL
8-K
2/10
Plains All American Pipeline appointed Cynthia B. Taylor as an independent board member, effective M
May 13, 2026
MIXED
8-K
6/10
Plains All American Pipeline completed the sale of its Canadian NGL business to Keyera Corp. for app
May 12, 2026
BULLISH
8-K
7/10
Plains All American reported Q1 2026 GAAP net income of $152M ($0.14/unit), down 66% YoY from $443M
May 8, 2026
NEUTRAL
DEFA14A
3/10
The filing is a definitive proxy statement for Plains All American Pipeline, L.P. (PAAPU), related t
Apr 10, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 50% buy across 24 analysts — 5 strong buy, 7 buy, 9 hold, 3 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 7 | 9 | 3 | 0 | 50% | |
| May 1, 2026 | 4 | 7 | 10 | 3 | 0 | 46% | |
| Apr 1, 2026 | 4 | 7 | 10 | 3 | 0 | 46% | |
| Mar 1, 2026 | 4 | 6 | 10 | 3 | 0 | 43% | |
| Feb 1, 2026 | 4 | 6 | 10 | 3 | 0 | 43% | |
| Jan 1, 2026 | 4 | 6 | 11 | 2 | 0 | 43% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.